Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety Study of Camptothecin-20-O-Propionate Hydrate (CZ48)
Phase 1
- Conditions
- Malignant Lymphoma of Extranodal and/or Solid Organ SiteSolid Tumor
- Interventions
- First Posted Date
- 2015-10-15
- Last Posted Date
- 2019-07-23
- Lead Sponsor
- Cao Pharmaceuticals Inc.
- Target Recruit Count
- 65
- Registration Number
- NCT02575638
- Locations
- 🇺🇸
University of Texas Health Science Center, San Antonio, Texas, United States
News
No news found